Keywords: Vivus, Qsymia, US launch, Weight loss

Vivus debuts weight-loss pill Qsymia on US market

Article | 19 September 2012

Print This

USA-based Vivus (Nasdaq: VVUS) saw its shares rise 3.9% to $22.93 on Monday, after the company announced the US market availability of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in